Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
DDS USA 2016 — 3rd Annual Drug Discovery USA Congress 2016
ID
821664
Dates
03 Oct 2016 - 04 Oct 2016
Location
San Diego, United States
Abstract
Oxford Global Conferences are proud to present the 3rd Annual Drug Discovery USA Congress, taking place on 3-4 October 2016 in San Diego, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.
Contact
Guillaume Alonso;     Phone: [1865248455];     Email: g.alonso@oxfordglobal.co.uk
Topics
Drug Discovery, medicinal chemistry, R&D, peptide drug discovery, strategies for target selection, genomic technologies, discovery research, novel stem cell assays, phenotypic screening strategies, primary cells, disease models, supporting innovation with informatics tools, new data analysis, integration platforms, ideas for efficient data exchange, gene editing.
2.
 
How to Prepare for an FDA Meeting — How to Prepare for an FDA Meeting
ID
829065
Dates
05 Oct 2016 - 06 Oct 2016
Location
Boston, United States
Abstract
How to Prepare for an FDA Meeting

FDA meetings are undeniably one of the most important steps in the development of medicinal products. Whether you are developing a drug, biological product, medical device, generic, diagnostic or anything else regulated by the FDA, it is a good idea to get direct feedback from the FDA about their concerns regarding your product before embarking on expensive and time-consuming development steps. FDA meetings need to be included in all product development strategies. However, the best answers are the one obtained by asking the best questions. Not only the best questions but the conduct of the meeting, management of time, efficiency of response, careful consideration of the answers, all could lead to successful conclusion to the meeting. This workshop would discuss the what, who, when and how of the FDA meetings. Steps from requesting a meeting, preparing and submission of the information package, preparing for the meeting, the conduct of the meeting and follow-up will be discussed using real-life experience and case studies.

Despite a few guidance documents to help sponsors prepare for meetings with the FDA, it is a challenge to understand the most efficient and productive ways to strategize, prepare, conduct, and follow-up for these meetings. There are many misconceptions about the expectations from these meetings both for the sponsor and the FDA, and hence many sponsors fail to get the most benefit from them. Over the years, the FDA has also revised processes and practices for meeting with sponsors.

This two day seminar will provide valuable tips about the logistics, planning, conduct and best practices for all kinds of meetings with the FDA. Throughout the workshop, the author will discuss case studies and examples to highlight the common errors and potential solutions. This workshop contains a collection of practical tips from the instructor’s extensive FDA meeting experience. This one-of-a-kind workshop will provide step-by-step instructions and practical tips to the most productive meeting with FDA for all FDA-regulated organizations.

Learning Objective:

Understanding all kinds of FDA meetings for drugs, biologics, medical devices, and all FDA-regulated meetings

When to and not to do meetings with FDA

Creating, managing and defending rationale for meetings with FDA

Requesting process for FDA meetings

Creating a meeting information package and its regulatory requirements

Logistics of an FDA Meeting

Best practices for FDA meeting follow up

Who Will Benefit:

Regulatory affairs professionals

Senior management executives (CEO, COO, CFO, etc.)

Project managers

Clinical trial specialists

Regulatory compliance associates and managers

People investing in FDA-regulated product development projects

Contact
Peter Brown;     Phone: [+1 410 501 5777];     Email: pbrown@fdamap.com
3.
 
Biomarker Summit Europe 2016
ID
824574
Dates
05 Oct 2016 - 07 Oct 2016
Location
Berlin, Germany
Abstract
The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, companion diagnostics, the health economics value of biomarkers, reimbursement environment, and perspective on cell free biomarkers for disease diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Biomarker, Diagnostics, Cell-Free Biomarkers
Related subject(s)
4.
 
Advanced Protein Aggregation & Characterization
ID
823718
Dates
06 Oct 2016 - 07 Oct 2016
Location
Vienna, Austria
Contact
Andrea Weber;     Phone: [+421257272145];     Email: andrea.weber@fleming.events
Topics
pharmacy, pharma, pharmacology, Drug, Protein, Protein agregates, agregation
5.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
819543
Dates
06 Oct 2016 - 07 Oct 2016
Location
Philadelphia, United States
Abstract
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
6.
 
European Pharmaceutical Market Access and Pricing & Reimbursement
ID
809088
Dates
10 Oct 2016 - 11 Oct 2016
Location
London, United Kingdom
Abstract
SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access. Learn about new strategies, their strengths, weaknesses and future implications.
Contact
Fateja Begum;     Phone: [+44 (0) 20 7827 6184];     Email: fbegum@smi-online.co.uk
Topics
pricing, market access, reimbursement, medicine, regulation, pharmacology,
7.
 
World ADC — World ADC San Diego
ID
803085
Dates
10 Oct 2016 - 13 Oct 2016
Location
San Diego, United States
Abstract
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Contact
Jenny Barlow;     Phone: [+1 212 537 5898];     Email: info@hansonwade.com
Topics
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
Event website
8.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749659
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Contact
Course Administrator;     Phone: [01865 286955];     Email: expther@conted.ox.ac.uk
Topics
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
9.
 
The Structure of Clinical Trials and Experimental Therapeutics
ID
828763
Dates
10 Oct 2016 - 14 Oct 2016
Location
Oxford, United Kingdom
Abstract
The Structure of Clinical Trials and Experimental Therapeutics course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Oncology Department and the Department for Continuing Education’s CPD Centre, the week will be led by Prof Rachel Kerr and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
Related subject(s)
10.
 
Myths and Urban Legends in Drug Development: Lessons Learned for Small Biotech Companies
ID
839259
Start date
11 Oct 2016
Location
Cambridge, United States
Abstract
Regis Technologies invites you for a seminar on "Myths and Urban Legends in Drug Development: Lessons Learned for Small Biotech Companies" delivered by guest speakers, Dr. Michelle Higgin and Dr. Lisa Lallos of PharmaDirections.
Contact
Kristine Biederer;     Phone: [1-847-697-6000];     Email: kbiederer@registech.com
Topics
Biotechnology
Related subject(s)
11.
 
Analytical Methods in Development and Manufacture of Drugs and Biologics: 2-Day In-Person Seminar by Ex-FDA Official
ID
834230
Dates
11 Oct 2016 - 12 Oct 2016
Location
San Francisco, United States
Abstract
Analytical methods ensure quality of drugs and biologics. During last 2 decades, paradigm for quality of pharmaceutical products has shifted from ensuring quality by testing representative samples to building quality during manufacture of such products, leading to the concept of Quality by Design (QbD). This course starts with discussing the new paradigm of quality, QbD, and role of analytical methods in ensuring quality.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Phone: [8887172436];     Email: referral@complianceonline.com
Topics
analytical methods development training, Quality by Design (QbD), verification, qualification, validation, bioassays, Good Manufacturing Practices (GMP)
12.
 
Cheminformantics for Drug Design
ID
825635
Start date
12 Oct 2016
Location
London, United Kingdom
Abstract
Cheminformatics for Drug Design: Data, Models & Tools Abstract Cheminformatics is a dynamic and rapidly evolving field which is at the heart of modern drug design. This meeting will allow medicinal chemists and scientists involved in drug design to meet and discuss the latest developments and best practices. The meeting topics will include decision-making using data and models, drug design tools for medicinal chemists, software for sharing ideas and collaboration.

The meeting will comprise a high quality programme of plenary lectures, plus both a poster session, and a commercial exhibition.

Contact
SoCI Conference Team;     Phone: [+44 (0)20 7598 1561];     Email: conferences@soci.org
13.
 
Pharma Expo
ID
800882
Dates
12 Oct 2016 - 14 Oct 2016
Location
Saint-Petersburg, Russia
Abstract
The 4th International exhibition of medicines, nutritional and dietary supplements Pharma will take place on 12-14 October 2016 in CEC EXPOFORUM in St. Petersburg.  International Exhibition of medicines, food and dietary supplements Pharma is important industry events for professionals in the medicine and pharmaceutical industry in the Northwest Russia.  The exhibition will be held as part of the St Petersburg International Health Forum.
Event website
14.
 
Training — Diabetes: An Overview
ID
791243
Start date
13 Oct 2016
Location
London, United Kingdom
Abstract
This introductory course provides an overview of the causes, mechanisms and management of diabetes from both a clinical management and a drug development perspective. Our expert speaker will introduce the pathogenesis of the disease and discuss current prevention and treatment options as well as the complications associated with diabetes. The complex inter-relationship with dyslipidaemias, hypertension, obesity and subsequent cardiovascular risk will be examined in some detail.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Clinical presentation and classification, Pathophysiology of T2 diabetes, Treatment options, Micro and macrovascular complications, Prevention of type 2 diabetes – the evidence
15.
 
International Paediatric Pharmaceutical Care Masterclass
ID
799970
Dates
13 Oct 2016 - 15 Oct 2016
Location
London, United Kingdom
Abstract
This is a highly practical masterclass designed by the expert pharmaceutical team at Evelina Children’s Hospital London, part of Guy’s and St Thomas’ NHS Foundation Trust. The masterclass combines case studies, lectures, role plays and patient case reviews at hospital bed sides.
Related subject(s)
16.
 
GPC — 3rd GCC Pharmacy Congress
ID
833686
Dates
17 Oct 2016 - 19 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
The GCC Pharmacy Congress is considered to be the most strategic Pharmaceutical platform in the region. Every year it attracts senior local, regional & international leaders from the pharmaceutical sector in hospitals, retail pharmacies, clinics, universities & government bodies.
Contact
Negin Bagherian;     Phone: [+97143619616];     Email: info@gccpharmacongress.com
17.
 
GCC Pharmacy Congress
ID
773534
Dates
17 Oct 2016 - 20 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
18.
 
WTCRF: Using Mixed Methods in Research
ID
807653
Start date
19 Oct 2016
Location
Edinburgh, United Kingdom
Abstract
Through a mixture of lectures and workshops, this one-day course will: - Discuss the long-standing “dichotomy” between quantitative and qualitative methods, and explore how these can be compatible when conducting mixed methods research - Explore the relevance of mixed methods designs for healthcare research and complex interventions - Explore the rationale behind “mixing” methods - Present the key taxonomies of mixed methods designs - Explore the epistemological underpinnings of mixed methods designs (pragmatism) - Provide a wider content for mixed methods research and link this to the Medical Research Council (MRC) Framework, and the principles of Implementation Science - Discuss the practicalities of designing and conducting mixed methods research as well as presenting related findings Date: Wednesday 19th October 2016 Time: 0930-1630 Venue: Seminar Room, Wellcome Trust Clinical research Facility, Western General Hospital, Edinburgh Course Fees: Student Rate: (valid matriculation card required) �40 NHS/Uni Early Bird Rate: (before 31 Aug 2016) �60 NHS/Uni Rate: (after 31 Aug 2016) �80 Industry: �160 For more information, or to book a place, please visit the WTCRF website www.crts.org.uk or contact us at wtcrf.education@ed.ac.uk or 44 (0)131 357 3355 Facebook: https://www.facebook.com/WTCRFEducationProgramme Twitter: @WTCRF_Education
Related subject(s)
19.
 
DIA16 — Discovery Informatics & Analytics Summit 2016
ID
828687
Dates
19 Oct 2016 - 20 Oct 2016
Location
London, United Kingdom
Abstract
This is the only event specifically focused on how to apply advanced informatics and analytics to unlock scientific insights at discovery phase. Transformational strategies and techniques have already been applied at the forefront of discovery informatics, and this year's event will showcase practical use cases of how to power drug discovery using these tools.

Uniting senior scientists from chemistry and biology, Discovery Informatics & Analytics 2016 offers inspirational keynote speeches, practical case studies offering immediate takeaways, interactive discussion sessions, and maximum opportunity to engage and network with colleagues from Europe and beyond.

Contact
Aman Sandhu;     Phone: [2037273100];     Email: aman.sandhu@lbcg.com
Topics
pharma, biotech, informatics, drug discovery
20.
 
RareX — RareX Rare Diseases Conference ft. ICORD
ID
803564
Dates
19 Oct 2016 - 22 Oct 2016
Location
Cape Town, South Africa
Abstract
The purpose of this conference is to provide a global forum for all stakeholders within the Rare Disease field, both locally and abroad, to participate in open discussion, enhance models of best practice and share specialist knowledge around rare diseases and orphan drugs. Incorporating the annual International Conference on Rare Diseases and Orphan Drugs (ICORD) for 2016, RareX has an extended program, to incorporate patients, their families and caregivers as well as support groups and minority groups within the rare disease community.
Contact
Renee;     Phone: [+27 (0) 21 683 2934];     Email: info@rarex.co.za
Topics
Rare Diseases, RareX, Orphan Drugs, Orphan diseases, ICORD, Rare Diseases South Africa
Related subject(s)
Event website
21.
 
Pharma Water Conference 2016
ID
834473
Start date
20 Oct 2016
Location
Mumbai, India
Abstract
Water is a key component in the manufacturing of all pharmaceutical products with it composing of even above 90% of the finished products in some cases. Hence, It is critical to understand the importance of maintaining high quality pharmaceutical water, meeting the regulatory requirements, enhancing design, qualification, validation and routine operation to ensure the quality manufacture of pharmaceuticals.

CPhI’s Pharma water Conference 2016 is a first of its kind platform for the pharmaceutical manufacturers and solution providers to network and discuss the major challenges around pharmaceutical water systems and brainstorm ways by which the industry meets the pharmacopeia requirements. This focused gathering strives to discuss strategies to produce and use high quality water for the manufacture of pharmaceuticals while ensuring no contamination in the pharmaceutical product or equipment

The main objective of this conference is to educate the attendees with the latest water solution technologies and understand the international methods and techniques to maintain high quality pharmaceutical water

Contact
Sean Palanna;     Phone: [91 22 61727272];     Email: sean.palanna@ubm.com
Topics
Pharmaceutical water, Equipment, Water Management
22.
 
NSCA — Nature SciCafe Asia 2016
ID
833412
Start date
24 Oct 2016
Location
Singapore, Singapore
Abstract
Nature SciCafe Asia is an invitation-only biotech forum for investors, entrepreneurs, scientists, government agencies and industry representatives. Only in its second run, the Nature SciCafe Asia has grown to be a series of biotech sessions that aims to develop a strong biotech investment environment in Asia, and connect rising stars in biomedical research to regional investment communities. In the forum, top biomedical investigators, handpicked by Nature Biotechnology and Nature Medicine, will speak of their translational and druggable work. These investigators have been chosen to present their cutting-edge work based on their scientific excellence and on the potential commercial interest of their research to an investor audience. Not forgetting the opportunity to network with influential scientists, investors as well as key representatives from academic institutions, pharmaceutical companies - including J&J Innovation and GSK, and government boards from the Asia Pacific region.
Contact
Nature SciCafe Asia;     Email: admin@naturesciencecafeasia.org
Topics
Nature SciCafe Asia, Nature, SciCafe, biotech, biotechnology, investors, entrepreneurs, scientists, government agencies, pharmaceutical companies, pharma, biomedical research, Nature Biotechnology, Nature Medicine, Nature, translational medicine, translational research, commercial interest, J&J Innovation, GSK, government, government board boards, APAC, Asia Pacific, Asia
23.
 
2nd Antibody Drug Conjugates Conference
ID
820031
Dates
24 Oct 2016 - 25 Oct 2016
Location
Boston, United States
Abstract
We invite you to attend the 2nd Antibody Drug Conjugates Conference, which will take place October 24-25, 2016 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
24.
 
7th Euro-Global Summit on Toxicology and Applied Pharmacology
ID
804860
Dates
24 Oct 2016 - 26 Oct 2016
Location
Rome, Italy
Abstract
Euro Toxicology 2016 enables the participants to “Connect, Collaborate and Perceive the Cutting Edge Research Works.” Eurotox aims to foster the spread of the newest advancements in the field of Toxicology and Pharmacology. It bestows a proficient platform to the students to traverse through the top notch research works by the leaders in the field.
Contact
Valentina Leyva;     Phone: [702-508-5197];     Email: valentinaleyva10@gmail.com
Topics
toxicology, pharmacology, euro toxicology 2016, eurotox, pathology, toxicology conference in Europe, genetics, genetic toxicology, toxicity, clinical toxicology, poison, experimental toxicology, clinical toxicologists
25.
 
ICBS2016-Madison — 5th Conference of the International Chemical Biology Society: Translational Chemical Biology
ID
829387
Dates
24 Oct 2016 - 26 Oct 2016
Location
Madison, WI, United States
Abstract
Following successful meetings in Boston, Kyoto, San Francisco and Berlin, ICBS presents its Fifth Annual Conference: Translational Chemical Biology. Twenty-two confirmed invited speakers plus 22 registrants selected from submitted abstracts will present oral presentations in nine sessions including infectious disease, cancer, neurodegenerative disorders, regenerative medicine, imaging and biosensors, epigenetics, natural products, lipids, and the human microbiome. Two poster sessions will be held with evening receptions. ICBS will again recognize three early-stage scientists in a Rising Stars of Chemical Biology session. ICBS2016-Madison will create a vibrant forum for the exchange of information on the latest advances in chemical biology and progress toward translation of these findings in important therapeutic areas.
Contact
Laura Richards;     Phone: [608-2656534];     Email: icbs@union.wisc.edu
Topics
chemical biology, drug discovery, imaging
26.
 
4th Antibody & Protein Therapeutics Conference
ID
820054
Dates
25 Oct 2016 - 26 Oct 2016
Location
Boston, United States
Abstract
We welcome you to the 4th Antibody & Protein Therapeutics Conference, which will be held October 25-26, 2016 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.
27.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811229
Dates
26 Oct 2016 - 28 Oct 2016
Location
Baltimore, MD, United States
Abstract
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Contact
Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
Immunogenicity, Clinical Relevance, Bioassays, Biologics
28.
 
Keystone Symposia: Translational Vaccinology for Global Health
ID
806823
Dates
26 Oct 2016 - 30 Oct 2016
Location
London, United Kingdom
Abstract
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Vaccines Immunology Infectious Diseases Global Health
Related subject(s)
29.
 
FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials — FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
ID
831550
Dates
27 Oct 2016 - 28 Oct 2016
Location
Boston, United States
Abstract
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Contact
Peter Brown;     Phone: [+1 410 501 5777];     Email: pbrown@fdamap.com
Topics
FDA GMP Regulations, Phase 1 Clinical trial, GMP Guidance Seminar, IND Submission, GMP for Medical Devices
30.
 
Training — Immunotherapies: An Introductory Overview
ID
791296
Start date
03 Nov 2016
Location
London, United Kingdom
Abstract
This one-day programme provides an introduction to immunotherapies. Immunotherapies are an increasingly important treatment method for a wide range of diseases. This training is developed specifically for pharmaceutical industry personnel and provides a thorough foundation to the subject applicable across therapy areas. It is ideal for individuals with little understanding of immunotherapies and equally beneficial to those with existing basic knowledge enabling further insight to the subject through detailed presentations and discussion with Healthcare’s expert physician faculty.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
The immune system – a guide, Introduction to immunotherapies, What goes wrong!, Examples in practice, The future
31.
 
BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
796066
Dates
07 Nov 2016 - 09 Nov 2016
Location
Cologne, Germany
Abstract
BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.
Contact
Catharine Moreno Finan;     Phone: [+49 89 2388 756-25];     Email: cmoreno@ebdgroup.com
Topics
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Related subject(s)
32.
 
Pharma Congress 2016 — World Pharma Congress
ID
829085
Dates
07 Nov 2016 - 09 Nov 2016
Location
Las Vegas, United States
Abstract
World Pharma Congress (Nov 07-09, 2016 Las Vegas, Nevada, USA) Organising Committee welcomes all Pharmaceutical experts around the globe. The conference series aims to provide a forum for worldwide researchers from various areas of Pharmacy, Medical, Health science and Life science by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Pharmaceutical Sciences.
Contact
Andrew Smith;     Phone: [7025085200];     Email: pharmacongress@pharmaceuticalconferences.com
Topics
pharma conferences, pharma summits, pharma events, pharma meetings, pharmaceutical conferences usa, international pharma conferences, drug conferences, babe conferences, babe summit.
33.
 
Biological Therapeutics
ID
828803
Dates
07 Nov 2016 - 11 Nov 2016
Location
Oxford, United Kingdom
Abstract
The Biological Therapeutics course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the course will be led by Professor Len Seymour, Professor of Gene Therapies, and Director of the Section of Clinical Pharmacology at the University of Oxford’s Department of Oncology, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
34.
 
E&L Europe 2016 — Extractables & Leachables Europe 2016
ID
808828
Dates
08 Nov 2016 - 10 Nov 2016
Location
Dublin, Ireland
Abstract
The Smithers Rapra Extractables & Leachables conferences, held in both the US and in Europe, are the only two of their kind. Both events deliver a cutting edge analysis of testing techniques and high level insight into the global regulatory landscape, while allowing extensive time for debate and networking.
Contact
Emma Newton;     Phone: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Topics
extractable, leachable, pharmaceutical, packaging, pharmaceutical testing, medical devices, e-cigarettes, packaging testing, mass-spectrometry
35.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805619
Start date
09 Nov 2016
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
Related subject(s)
36.
 
Equivalence of Complex Drug Products: Scientific and Regulatory Challenges
ID
834766
Start date
09 Nov 2016
Location
New York, United States
Abstract
The rise of bio- and nano-technologies has accelerated the development of complex drug products, a class of products that include—but are not limited to—Non Biological Complex Drugs (NBCDs). NBCDs (e.g., glatiramoids, iron-carbohydrate complexes, polymeric micelles, complex ocular emulsions, and liposomes) consist of different (closely related and often nanoparticulate) structures that cannot be fully quantitated and characterized by physico-chemical analytical means. The complex nature of NBCDs means that minute variations in the manufacturing process can substantially change the composition of final products, and this poses a challenge for the development of regulatory guidelines. While guidance for developing generic versions of small molecule drugs is well-established, and progress has been made for biologic complex drugs, there is very little guidance for follow-on versions of NBCDs. This is further complicated by the difficulty of aligning strategies of international regulatory bodies due to their different legal frameworks. To advance research and build consensus, it is necessary to engage together key stakeholders from academia, regulatory bodies, industry, and drug manufacturing.
Topics
complex drugs, biosimilars, generics, biologics, drug discovery, drug development, regulation, nanotechnology, nano-technology, drug delivery, drug release
37.
 
HTMD — 3RD WORKSHOP ON HIGH THROUGHPUT MOLECULAR DYNAMICS (2016)
ID
839615
Dates
10 Nov 2016 - 11 Nov 2016
Location
Barcelona, Spain
Abstract
The aim of this workshop is to learn the latest developments of high-throughput molecular dynamics simulations with practical lectures and real data and to give scientists the opportunity to exchange their experiences. Hands-on session and training will be given using HTMD a powerful programmable environment to prepare, handle, simulate and analyze molecular simulations, and efficient GPU-based MD simulations, and standard protocols to execute numerical experiments. At the end of the workshop there will be a session on applying what you have learned on your data/proteins.

Thanks to sponsoring from Nvidia two GPUs will be awarded to the best contributed talk and poster. Amazon EC2 will also be used during the workshop.

The high arithmetic performance of recent GPUs offers an important technological advance for molecular dynamics simulations but real benefits are only apparent if thousands of simulations are used, i.e. high-throughput. Environments like HTMD are designed to get the scientist to focus on the science and applications, rather than the technicalities.

This workshop is a great opportunity for industrial partners to get an overview of the state-of-the-art in molecular simulations for medicinal chemistry and drug design.

Contact
Maria Saarela;     Email: htmd@acellera.com
Topics
HTMD, high throughput molecular simulation, protein, GPU, medicinal chemistry, drug design
38.
 
WPE — Inaugural World Preclinical Congress Europe
ID
820676
Dates
14 Nov 2016 - 16 Nov 2016
Location
Lisbon, Portugal
Abstract
The World Preclinical Congress Europe is a key networking event bringing together a global audience involved in preclinical research. It features conferences and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. With the broad range of conference's covered, the event offers a diverse cross-disciplinary environment for tackling translational challenges and sharing best practices. It’s where preclinical minds meet discovery technologies to innovate traditional drug discovery by sharing ideas, showcasing new technologies, and fostering new collaborations.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
medicinal chemistry, lead optimization, drug toxicity, preclinical research, cancer immunotherapy, CRISPR, drug discovery
39.
 
ICI Europe
ID
838753
Dates
16 Nov 2016 - 18 Nov 2016
Location
Munich, Germany
Abstract
Returning for the second year, ICI (Immune Checkpoint Inhibitors) Europe 2016 focuses exclusively on how to deliver maximum clinical benefit through immune checkpoint monotherapy and combinations. Incorporating insights from Bristol-Myers Squibb, Merck Sharpe and Dohme and Genentech, this meeting will deliver practical learning on what it takes to develop the next generation of ICI drugs, from pathway validation to clinical success.
Contact
Jenny Barlow;     Phone: [+44 (0)20 3141 8700];     Email: info@hansonwade.com
Topics
ICI, Immune, Checkpoint, Inhibitors
Related subject(s)
40.
 
2nd Pre-Connect Congress 2016
ID
834818
Dates
17 Nov 2016 - 18 Nov 2016
Location
Mumbai, India
Abstract
The Conference aims to explore the latest trends and advancements in the Indian pharmaceutical industry.
Contact
Mustafa Nalwalla;     Phone: [22 6172 7067];     Email: mustafa.nalwalla@ubm.com
41.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788204
Dates
17 Nov 2016 - 20 Nov 2016
Location
Singapore, Singapore
Abstract
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Contact
Conference Secretariat;     Phone: [+65 6570 6280];     Email: info@apamt2016.com
Topics
Toxicology Poison Analysis Chemical Environmental Toxinology
42.
 
Antibodies Targeting GPCRs, Recent Advances and Therapeutic Challenges
ID
830065
Dates
24 Nov 2016 - 25 Nov 2016
Location
Tours, France
Abstract
The conference will be organized as a satellite workshop of the 5th meeting of GDR 3545 on “G Protein-Coupled Receptors (GPCRs) - From Physiology to Drugs” to be held in Tours, Val de Loire (France). The topic of the workshop will focus on new advances and challenges in the development of antibodies targeting GPCRs and their potential applications in clinic. GPCRs represent the largest family of cell surface receptors regulating many human and animal physiological functions. Their implication in human pathophysiology is obvious with about 15% of GPCRs being targeted by 30-40% of the medical drugs commercialized today. Developing therapeutic antibodies directed against GPCRs appears as a promising alternative to selectively and safely modulate their activity. Several speakers from academia and industry considered as leaders in antibody development against GPCRs have accepted to take part in the event. The recent technological strategies used for immunization as well as for development of various antibodies formats (i.e. IgGs, scFv and nanobodies) will be presented. Moreover, the prospective of application of GPCR-selective antibodies in the most important physiological systems such as the central nervous, the immune, and the endocrine systems will be essentially covered.
Topics
GDR, G Protein-Coupled Receptors, GPCRs, antibodies, therapeutic antibodies
Related subject(s)
43.
 
International Congress on Immunology and Vaccine Research
ID
817911
Dates
28 Nov 2016 - 30 Nov 2016
Location
Dubai, United Arab Emirates
Abstract
Immuno congress - 2016 is organized in association with Journal of Immunological Diseases, Disorders and their Prevention, an open access and peer reviewed journal that publishes articles in the field of experimental, clinical immunology, host defense, autoimmune disorders and other related topics. Immunology is a branch of biomedical science that covers the study of all dimensions of immunology. The immunology journal aims in covering the recent technologies and findings in the field of medical science.
Contact
Dhwani Hissaria;     Phone: [1-646-202-2876];     Email: immunocongress2016@clytoaccess.com
Related subject(s)
44.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773684
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Related subject(s)
45.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789581
Dates
29 Nov 2016 - 30 Nov 2016
Location
Munich, Germany
Abstract
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Contact
BioM Biotech Cluster Development GmbH;     Phone: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Topics
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
Event website
46.
 
MPMC — MENA Pharmaceutical Manufacturing Congress
ID
802929
Dates
29 Nov 2016 - 01 Dec 2016
Location
Jeddah, Saudi Arabia
Abstract
The MENA Pharmaceutical Manufacturing Congress, will set a unique platform by gathering the pioneers of local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulators affairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing. The congress will include case studies, presentations, and interactive panel discussions which will focus on issues such as the obstacles fronting the pharmaceutical industry, the integration between the different concerned entities, and the future of the industry in the region. The conference will also be accompanied by an exhibition that features the latest machinery and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, and the regional manufacturers in the country. Join the MENA Pharmaceutical Manufacturing Congress, to gain knowledge and learn about the innovative strategies which are driving the growth of the pharmaceutical manufacturing in the MENA region, and leading the industry towards excellence.
Contact
Yarina;     Phone: [+971 4 361 9616];     Email: info@pharmamanufacturingmena.com
Topics
Pharmaceutical, Manufacturing, Drug, MENA
47.
 
PharmaMed-2016 — International Conference on Medicinal and Pharmaceutical Chemistry
ID
812385
Dates
05 Dec 2016 - 07 Dec 2016
Location
Dubai, United Arab Emirates
Abstract
International Conference on Medicinal and Pharmaceutical Chemistry is going to be held during December 5-7, 2016 at Crowne Plaza, Dubai, UAE. This scientific conference bring upon a new platform to share and discuss all the innovations in the Medicinal and Pharmaceutical Chemistry.
Contact
James Martin;     Phone: [+1-302-231-6959];     Email: pharmamed@madridge.com
Topics
Molecular Modeling and Computer-Aided Drug Design, Drug Discovery from Synthetic and Natural Sources, Drug Design and Drug Delivery, Biopharmaceutics, Chemical Biology and Biophysics, Pharmacology, Toxicology and Pharmacogenomics, Pharmacodynamics and Pharmacokinetics, Pharmaceutical Analysis: Analytical Methods, Pharmaceutical Market, Antibiotics and Anti Cancer Drugs, Advances in Drug Discovery and Medicinal Chemistry, Pharmacology Applications in Medicine.
48.
 
4th Protein Expression, Purification & Characterization Conference
ID
825854
Dates
05 Dec 2016 - 07 Dec 2016
Location
Boston, United States
Abstract
GTCbio is proud to present the 4th Protein Expression, Purification & Characterization Conference to be held on October 24-26, 2016 in Boston, MA. This meeting covers important topics including discussions on the expression of difficult proteins, new methods of purification, extended characterization of production cell lines, expression of difficult proteins, and new efficent analytical tools.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
Protein Expression, Purification & Characterization
49.
 
BAC — 3rd Annual Re-Entering Antibacterial Discovery and Development Summit
ID
825108
Dates
07 Dec 2016 - 09 Dec 2016
Location
Boston, United States
Abstract
By holding the Re-Entering Antibacterial Discovery and Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to overcome the crisis of multidrug resistance, to revive the antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange among all stakeholders participating in discovery and development of new antibacterial agents. It includes several events listed below.
Contact
Pete DeOlympio;     Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
Compound validation, Preclinical development, Clinical phases, Regulatory concerns and pathways, Partnership seeking
50.
 
IMVACS — 11th Annual Immunization & Vaccine Summit
ID
825050
Dates
07 Dec 2016 - 09 Dec 2016
Location
Boston, United States
Abstract
Globally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.
Contact
Phone: [781-972-5400];     Email: chi@healthtech.com
Topics
DNA- and RNA- Based Vaccines, Advances in Vaccine Technologies, Vaccine Adjuvants
Related subject(s)
Event website
51.
 
Pre-Filled Syringes Europe 2017
ID
839119
Dates
18 Jan 2017 - 19 Jan 2017
Location
London, United Kingdom
Abstract
Now leading the path in presenting the industry with all the necessary updates on injectable devices, SMi Group returns to Central London on 18th & 19th January 2017 to proudly host the 9th annual conference and exhibition: Pre-Filled Syringes Europe. Pre-Filled Syringes Europe 2017 will once again gather an audience of senior scientists, device manufacturers and PFS market professionals, providing a focal point to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. The best line-up yet will include speakers from Novartis, MHRA, USB, Sanofi, GSK, Glenmark, Sandoz, Teva, Novartis, Janssen Pharmaceuticals, F. Hoffmann-La Roche, Boehringer Ingelheim and more!
Contact
Teri Arri;     Phone: [2078276000];     Email: tarri@smi-online.co.uk
Topics
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd
52.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830095
Dates
22 Jan 2017 - 26 Jan 2017
Location
Snowbird, Utah, United States
Abstract
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Cancer, drug discovery, immunology
53.
 
Drug Development, Pharmacokinetics and Imaging
ID
828751
Dates
23 Jan 2017 - 27 Jan 2017
Location
Oxford, United Kingdom
Abstract
The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0) 01865 286955];     Email: expther@conted.ox.ac.uk
54.
 
Biologistics World Asia 2017
ID
827165
Dates
15 Feb 2017 - 16 Feb 2017
Location
Singapore, Singapore
Abstract
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
55.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811305
Dates
20 Feb 2017 - 22 Feb 2017
Location
Baltimore, United States
Abstract
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Contact
James Martin;     Phone: [1-302-231-6959];     Email: Vaccines@madrige.com
Topics
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
56.
 
12th Annual Biomarkers Congress
ID
839709
Dates
21 Feb 2017 - 22 Feb 2017
Location
Manchester, United Kingdom
Abstract
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Contact
Danielle Dalby;     Phone: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Related subject(s)
57.
 
Frontiers in Cancer Immunotherapy
ID
824447
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Related subject(s)
58.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825322
Dates
05 Mar 2017 - 09 Mar 2017
Location
Breckenridge, Colorado, United States
Abstract
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
59.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828816
Dates
06 Mar 2017 - 10 Mar 2017
Location
Oxford, United Kingdom
Abstract
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
60.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833099
Dates
13 Mar 2017 - 15 Mar 2017
Location
London, United Kingdom
Abstract
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Contact
Renaldo Howell;     Phone: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
61.
 
Health Economics for Non-Health-Economists
ID
834363
Dates
16 Mar 2017 - 17 Mar 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
62.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825268
Dates
19 Mar 2017 - 22 Mar 2017
Location
Tahoe City, California, United States
Abstract
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Related subject(s)
63.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825241
Dates
19 Mar 2017 - 23 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Related subject(s)
64.
 
8th Annual Biotherapeutics Analytical Summit
ID
829794
Dates
20 Mar 2017 - 23 Mar 2017
Location
Bethesda, United States
Abstract
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Contact
Bethany Gray;     Phone: [781-972-5400];     Email: chi@healthtech.com
65.
 
Keystone Symposia - HIV Vaccines
ID
825269
Dates
26 Mar 2017 - 30 Mar 2017
Location
Steamboat Springs, Colorado, United States
Abstract
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Related subject(s)
66.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811647
Dates
13 Apr 2017 - 16 Apr 2017
Location
Girne (Kyrenia), Cyprus, Turkey
Related subject(s)
Event website
67.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828975
Dates
24 Apr 2017 - 26 Apr 2017
Location
Dubai, United Arab Emirates
Abstract
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Contact
Mythrei Syria;     Phone: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Topics
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
68.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825353
Dates
01 May 2017 - 04 May 2017
Location
Estes Park, Colorado, United States
Abstract
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Related subject(s)
69.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828804
Dates
08 May 2017 - 12 May 2017
Location
Oxford, United Kingdom
Abstract
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
70.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834280
Start date
09 May 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
71.
 
Principles of Pharma Market Access in Europe
ID
834261
Dates
16 May 2017 - 17 May 2017
Location
Zurich, Switzerland
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
72.
 
Value Pricing for Market Access - The Fundamentals
ID
834344
Dates
18 May 2017 - 19 May 2017
Location
Zurich, Switzerland
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
73.
 
Biologistics World Korea 2017
ID
827175
Dates
23 May 2017 - 24 May 2017
Location
Seoul, South Korea
Abstract
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Contact
Andrew Darwitan;     Phone: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
74.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831645
Dates
13 Jun 2017 - 15 Jun 2017
Location
London, United Kingdom
Contact
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Topics
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
75.
 
Health Economics for Non-Health-Economists
ID
834384
Dates
20 Jun 2017 - 21 Jun 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
76.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781802
Dates
20 Jun 2017 - 23 Jun 2017
Location
Albufeira, Portugal
Abstract
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Related subject(s)
77.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828721
Dates
03 Jul 2017 - 07 Jul 2017
Location
Oxford, United Kingdom
Abstract
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Contact
Course Administrator;     Phone: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
78.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827434
Dates
24 Jul 2017 - 26 Jul 2017
Location
Melbourne, Australia
Abstract
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Contact
Robert Brown;     Phone: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Topics
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
79.
 
Principles of Pharma Market Access in Europe
ID
834282
Dates
03 Oct 2017 - 04 Oct 2017
Location
Brussels, Belgium
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
80.
 
Value Pricing for Market Access - The Fundamentals
ID
834387
Dates
05 Oct 2017 - 06 Oct 2017
Location
Brussels, Belgium
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
81.
 
Health Economics for Non-Health-Economists
ID
834427
Dates
12 Oct 2017 - 13 Oct 2017
Location
Zurich, Switzerland
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
82.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834378
Start date
30 Nov 2017
Location
Brussels, Belgium
Abstract
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
83.
 
Principles of Pharma Market Access in Europe
ID
834358
Dates
05 Dec 2017 - 06 Dec 2017
Location
London, United Kingdom
Abstract
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
84.
 
Value Pricing for Market Access - The Fundamentals
ID
834408
Dates
07 Dec 2017 - 08 Dec 2017
Location
London, United Kingdom
Abstract
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
85.
 
Health Economics for Non-Health-Economists
ID
834448
Dates
14 Dec 2017 - 15 Dec 2017
Location
Brussels, Belgium
Abstract
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Contact
Annelies Swaan;     Phone: [+32027090142];     Email: annelies.swaan@celforpharma.com
Related subject(s)
86.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839627
Dates
13 May 2018 - 16 May 2018
Location
Madrid, Spain
Abstract
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Contact
Vikki Hyman;     Phone: [+97235175150];     Email: eilat@target-conferences.com
Topics
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Related subject(s)
Event website
Superbugs & Superdrugs USA Conference & Exhibition

Good to know...

You can advertise your event or services in this space.

Last updated: 22 September 2016